WO2007059483A2 - Stent and stent delivery system for ostial locations in a conduit - Google Patents
Stent and stent delivery system for ostial locations in a conduit Download PDFInfo
- Publication number
- WO2007059483A2 WO2007059483A2 PCT/US2006/060865 US2006060865W WO2007059483A2 WO 2007059483 A2 WO2007059483 A2 WO 2007059483A2 US 2006060865 W US2006060865 W US 2006060865W WO 2007059483 A2 WO2007059483 A2 WO 2007059483A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- section
- balloon
- tubular
- struts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/821—Ostial stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
Definitions
- the present invention relates to luminal implants, and, more particularly, to stents for use in treating vascular disease.
- Stents are widely used for supporting a lumen structure in a patient's body.
- a stent may be used to maintain patency of a coronary artery, other blood vessel or other body lumen such as the ureter, urethra, bronchus, esophagus, or other passage.
- a stent is typically a metal, tubular structure, although polymer stents are known.
- Stents can be permanent enduring implants, or can be bioabsorbable at least in part.
- Bioabsorbable stents can be polymeric, bio- polymeric, ceramic, bio-ceramic, or metallic, and may elute over time substances such as drugs.
- the stent is an open-celled tube that is expanded by an inflatable balloon at the deployment site.
- Another type of stent is of a "self-expanding" type.
- a self-expanding stent does not use a balloon or other source of force to move from a collapsed state to an expanded state.
- a self- expanding stent is passed through the body lumen in a collapsed state.
- the stent is expanded to its expanded diameter for its intended purpose.
- An example of a self-expanding stent is a coil structure that is secured to a stent delivery device under tension in a collapsed state.
- Coil stents can be manufactured using a variety of methods, such as winding of wire, ribbon, or sheet on a mandrel or by laser cutting from a tube, followed by the appropriate heat treatments.
- Another type of self expanding stent is an open-celled tube made from a self-expanding material, for example, the Protege GPS stent from ev3, Inc. of Madison, MN.
- Open cell tube stents are commonly made by laser cutting of tubes, or cutting patterns into sheets followed by or preceded by welding the sheet into a tube shape, and other methods.
- the shape, length and other characteristics of a stent are typically chosen based on the location in which the stent will be deployed.
- selected segments of the human vasculature present specific challenges due to their shape and configuration.
- One such situation involves the ostium of short renal arteries within the human body.
- stents are generally designed for segments of long cylindrical vessels. When such stents are deployed at the ostium of short renal arteries, in an attempt to prevent further progression of arteriosclerosis disease from aorta into renals, they may extend into the aorta and disrupt the normally laminar blood flow. This result further compounds an existing need to minimize disruption of the flow pattern at the ostium.
- stents are hard to position on a consistent basis at the precise ostial location desired, and placement of renal stents can release arteriosclerotic debris from the treatment area. Such debris will flow distally into the kidney and embolize, causing impaired renal function.
- the stent when flared, has a lower percentage of coverage of vessel wall at flared regions than is desirable. It is known that stent struts, when expanded into contact with the vessel wall, should cover a certain percentage of the internal vessel wall area in order to prevent prolapse of tissue through the open spaces between stent struts.
- a renal stent comprises a balloon expandable segment which is deployed in the renal vessel and a self expanding segment which is deployed in the aortic segment.
- Either or both of the balloon expandable and self expanding segments can be deployed in the ostial region of the renal vessel, typically the renal artery.
- the balloon expandable segment provides superior radial strength for maintaining dilated diameter of the renal vessel.
- the self expanding segment expands to conform to the flared ostial and aortic regions of the vessel.
- the self expanding segment can be balloon dilated to enhance conformance of the self expanding stented segment to the ostial and aortic regions.
- a stent for insertion into a body lumen comprises a first tubular, self-expanding section; a second tubular, balloon-expandable section; and a mechanism for limiting axial movement of the first and second tubular sections relative to each other.
- a stent for insertion into a body lumen comprises a tube formed of a uniform material having i) a first section to which a first process is applied, and ii) a second section to which a second process is applied; and wherein the expansion characteristics of the first and second sections within the body lumen are different.
- a stent for insertion into a body lumen comprising a plurality of sections, each section defining a plurality of cells, each cell atleast partially defined by a plurality of struts, selected of the struts in each section connecting to struts of an adjacent stent section, wherein the number of connecting struts between adjacent segments increases proximally.
- system for delivering a medical device within a body lumen comprises: a tubular catheter having proximal and distal ends and comprising an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising i) a first tubular, balloon- expandable section; and ii) a second tubular, self-expanding section; and wherein the first section of the medical device is disposed intermediate the first balloon and the outer shaft member, and wherein the second section of the medical device is disposed intermediate the second balloon and outer shaft member.
- a method for placement of a medical device within a body lumen comprises: disposing a delivery system within the body lumen, the delivery system comprising: a tubular catheter having an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising: i) a first balloon-expandable section disposed intermediate the first balloon and the outer shaft member, and a second self-expanding section disposed intermediate the second balloon and outer shaft member.
- the method further comprises withdrawing the outer shaft member proximally to expose the first balloon- expandable section of the medical device to the body lumen; inflating the first balloon to expand the first section of the medical device against the body lumen; withdrawing the outer shaft member proximally to expose the second self-expanding section of the medical device to the body lumen; and inflating the second balloon to expand the second section of the medical device at least partially against the body lumen.
- Figures 1 -4 illustrate conceptually a partial cross-sectional diagram of a stent and a plan view of a stent delivery system in accordance with the present invention
- Figure 5 illustrates conceptually an alternate embodiment of the delivery system of Figures 1-4;
- Figure 6 illustrates conceptually a cross-sectional diagram of another embodiment of a stent in accordance with the present invention
- Figure 7 illustrates conceptually a plan view of an alternative embodiment of a stent in accordance with the present invention
- Figure 8 is a schematic diagram of a stent in accordance with the present invention
- Figure 9 illustrates conceptually a plan view of an alternate embodiment of a stent in accordance with the present invention
- Figure 10 illustrates conceptually the profile of a flared stent in accordance with the present invention
- Figures 11 and 11A are schematic diagrams of an alternate embodiment of a stent in accordance with the present invention.
- Figures 12 and 13 illustrate conceptually a plan view of another embodiment of a stent in accordance with the present invention.
- Figures 14 is a schematic diagrams of a film material used in the stent embodiment of Figure 17;
- Figures 15 and 16 illustrate conceptually exploded and compressed cross-sectional diagram, respectively, of a film suitable for use with the stent embodiment of Figure 17;
- Figure 17 illustrates conceptually a plan view of another embodiment of a stent in accordance with the present invention.
- Figure 1 illustrates a stent 15 in accordance with the present invention.
- Stent 15 comprises a balloon expandable stent segment 12 and a self expanding stent segment 13.
- Balloon expandable stent segment 12 may comprise stainless steel alloys, cobalt chrome alloys, titanium, tantalum, platinum, gold, or other materials or their alloys as are known in the art.
- the self expanding stent segment 13 may be comprise high elastic limit materials such as Elgiloy, cobalt chrome alloys, or other materials as are known in the art.
- the self expanding stent may comprise so-called shape-memory metals such as nitinol. Shape-memory metal stents can self-expand when thermo mechanically processed to exhibit superelastic material properties.
- Such shape-memory stents can also self-expand through use of a pre- programmed shape memory effect.
- Stents processed to exhibit a shape memory effect experience a phase change at the elevated temperature of the human body. The phase change results in expansion of the stent from a collapsed state to an enlarged state
- FIGS 1 — 4 show delivery of the inventive stent 15 to a treatment site.
- the renal stent 15 is delivered to the treatment site, typically a renal artery, on a catheter 18 with both an outer sheath 11 coaxially retractable from inner balloons 10, 16, as illustrated in figure 1.
- the outer sheath 11 constrains at least the self expandable segment 13 of the stent 15.
- Distal balloon 10 is used to expand the balloon expandable segment 12 of the stent 15.
- Optional proximal balloon 16 may be used to dilate the self expanding segment 13 of stent 15.
- distal balloon 10 is inflated to expand the balloon expandable segment 12 and dilate the artery RA, thereby fixing the stent at the treatment site, as illustrated in Figure 2.
- Outer sheath 11 is then withdrawn, preferably before deflation of distal balloon 10, and self expanding segment 13 diametrically enlarges and conforms to the typically flared ostial O and/or aortic Ao regions near the vessel, as illustrated in Figure 3.
- the flared portion of the stent 15, that is the portion of the stent 15 opposite the ostial O and aortic Ao regions can be further dilated with proximal balloon 16.
- Inflated distal balloon 10 helps to axially anchor catheter 18 in vessel RA so that proximal balloon 16 can deliver force to self expandable stent segment 13 and thereby enhance stent segment 13 apposition to ostial and aortic regions of the vessel.
- Balloons 10 and 16 are then deflated.
- the outer sheath 11 is advanced relative to balloons 10 and 16 to cover the balloons in whole or in part, and the stent delivery catheter 18 is withdrawn from the treatment site, as illustrated in Figure 4.
- balloon expandable stent segment 12 in the vessel RA with precision because subsequent expansion of the self expanding stent segment 13 will assure continuous coverage of the vessel wall in regions RA 1 O, and Ao.
- Stenting of the vessel RA, ostium O, and aorta Ao is accomplished by delivery of one stent to the region thereby reducing the amount of debris generated during stenting as compared to procedures involving delivery of multiple devices.
- Fig. 5 shows an alternate embodiment of a delivery system 18' shown in Figures 1-4.
- the delivery system shown in Fig. 5 is used in a manner similar to that described above in conjunction with Figs. 1 - 4.
- balloon 17 provides the function of both balloons 10 and 16 of delivery system 18'. With sheath 11 covering self expanding stent segment 13 and balloon portion 17b, balloon portion 17a is used to dilate balloon expandable stent segment 12. Subsequently, balloon 17 is deflated to a pressure low enough to proximally withdraw sheath 11 until it no longer covers self expanding stent segment 13 and balloon portion 17b.
- balloon 17 is inflated, causing balloon portion 17a to anchor catheter 18 in the vessel and causing balloon portion 17b to further dilate self expanding stent portion 13.
- balloon 17 may be constructed from appropriate materials so as to have differing compliance characteristics between sections 17a and 17b at the same inflation pressure, or , balloon 17 may be formed to assume a profile similar to that illustrated in Figure 5.
- Fig. 6 illustrates another embodiment of the inventive stent 15 in which the stent segments are at least partially coextensive.
- the balloon expandable segment 1 disposed within the self expanding segment 2, as shown.
- the balloon expandable segment 1 can be arranged outside of the self expanding segment 2 (not shown).
- the balloon expandable and self expandable segments may be attached to each other so as to limit axial motion of one segment relative to the other.
- the stent segments can be attached to one another using means 3 known in the art, including, but not limited to, mechanical interlock, welding, adhesive bonding, over molding, sintering, diffusion bonding, cladding, explosive bonding, ultrasonic welding.
- stent segments 1 and 2 may have matched axial shortening or lengthening during expansion to prevent detachment of attachment sites of means 3.
- stent segments 1 and 2 can have mis-matched axial shortening or lengthening during expansion provided the attachment sites of means 3 are designed to accommodate such mis-match without becoming detached.
- Fig. 7 illustrates another alternative embodiment of the inventive stent 15.
- stent 15 comprises a balloon expandable segment 1 and a self expanding segment 2.
- the balloon expandable segment 1 is attached to the self expanding segment 2 at attachment region 20.
- the balloon and self expandable stent segments may be attached to each other so as to limit axial motion of one segment relative to the other.
- the stent segments can be attached to one another using means known in the art, including, but not limited to, mechanical interlock, welding, adhesive bonding, over molding, sintering, diffusion bonding, cladding, explosive bonding, ultrasonic welding.
- a stent segment 1 comprising a titanium alloy can be welded to a stent segment 2 comprising Nitinol.
- Figure 8 illustrates an example of implementation of the stent of figure 7.
- stent 15 comprises laser cut tubular stent segments 1 and 2 welded at attachment points 5 in attachment region 20.
- the longitudinal axis of stent 15 is indicated in the figure by dashed line "X.”
- FIG. 9 illustrates another alternative embodiment of a stent 15 having a singular piece of material to which different processes have been applied.
- stent 15 comprises stent segments 1 and 2 having different overall processing histories.
- a body temperature superelastic nitinol stent may be heated in the region of stent segment 1 to raise the transition temperature in segment 1 to above body temperature, resulting in a balloon expandable stent segment 1 and a self expanding stent segment 2.
- an Elgiloy or cobalt- chrome alloy stent initially heavily work hardened and self expanding, may be preferentially annealed to render a portion of the stent balloon expandable.
- Fig. 10 illustrates a side cut-away profile of another alternative embodiment of a stent 15 having cell designs with the same number of struts along its length.
- the stent struts in non-flared region 41 having stent diameter D, the stent struts have approximately 14 - 18% metal coverage area.
- the stent struts In flared region 42 having stent diameter 2D, the stent struts have approximately 7 - 9% metal coverage area.
- flared region 43 having stent diameter 4D 1 the stent struts have approximately 3.5 — 4.5% metal coverage area.
- stents having metal coverage area less than approximately 14 — 18% do not perform well due to tissue prolapse through the cells of the stent into the stented lumen, and due to potential extrusion of atheromatous material through the stent metal coverage area into the stented vessel lumen.
- One way to do this is by increasing the number of stent struts in region of the stent that will be flared as compared to the number of struts in the region of the stent that will not be flared.
- Figures 11 and 11A illustrate a stent embodiment for increasing the percent metal coverage area in the flared region of the deployed stent.
- the number of struts progressively increases in regions 41 , 42, and 43 respectively.
- the compressed stent diameter is held constant while the compressed strut spacing varies in segments 41 , 42, and 43.
- Attachment points between regions in this embodiment may comprise a laser cut tube segment, as illustrated in detail in Figure 11 A, with the number of connecting struts increasing between adjacent segments as the density of the cell/strut configuration increases between adjacent segments.
- segment 41 comprises 6 struts
- segment 42 comprises 12 struts
- segment 43 comprises 24 struts. It is recognized that any number of struts and segments may be used to produce an overall stented region metal coverage area of a target value appropriate to the anatomy. For arteries the illustrative target metal coverage area is thought to be approximately 15 — 18%.
- Stent 15 comprises balloon expandable segment 1 and self expanding segment 2.
- Balloon expandable segment 1 may have the construction and function similar any of the embodiments described herein.
- Self expandable segment 2 comprises leafs 50 and film 52.
- Leafs 50 comprise materials such as those described above for self expanding stent segment 2.
- Leafs 50 are attached to balloon expandable stent segment 1 using techniques similar to those described above regarding the embodiment of Fig. 7.
- Film 52 is attached to leafs 50 by bonding.
- Film 52 may comprise any of a variety of membranous materials including those which facilitate cellular ingrowth, such as ePTFE. The suitability of alternate materials for film 52 can be determined through routine experimentation.
- the film 52 may be provided on one or both radially facing sides of the leafs 50.
- the film 52 comprises two layers, with one layer on each side of leafs 50. The two layers may be bonded to each other around the leafs using any of a variety of techniques, for example by heat bonding, with or without an intermediate bonding layer such as polyethylene or FEP, adhesives, sutures, or other techniques which will be apparent to those of recently skill in the arts in view of the disclosure herein.
- the film 52 preferably has a thickness of no more than about 0.006" and a pore size within the range of from approximately 5 ⁇ m to approximately 60 ⁇ m.
- Film 52 in one embodiment preferably is securely attached to leafs 50 and retains a sufficient porosity to facilitate cellular ingrowth and/or attachment.
- a bonding layer 254 preferably comprises a mesh or other porous structure having an open surface area within the range of from about 10% to about 90%. In one embodiment, the open surface area of the mesh is within the range of from about 30% to about 60%.
- the opening or pore size of the bonding layer 254 may be within the range of from about 0.005 inches to about 0.050 inches, and, in one embodiment, is about 0.020 inches.
- the thickness of the bonding layer 254 can be varied widely, and is generally within the range of from about 0.0005 inches to about 0.005 inches. In a illustrative embodiment, the bonding layer 254 has a thickness of about 0.001 to about 0.002 inches.
- One suitable polyethylene bonding mesh is commercially available from Smith & Nephew Inc., Memphis, Tennessee under the code SN9.
- Figure 15 is an exploded view illustrating the relationship between first membrane 250, second membrane 252, bonding layer 254 and leafs 50.
- Bonding layer 254 is disposed adjacent one or both sides of leafs 50.
- the bonding layer 254 and leafs 50 are then positioned in-between a first membrane 250 and a second membrane 252 to provide a composite membrane stack.
- the first membrane 250 and second membrane 252 may comprise any of a variety of materials and thicknesses, depending upon the desired functional result. Generally, the membrane has a thickness within the range of from about 0.0005 inches to about 0.010 inches.
- the membranes 250 and 252 each have a thickness on the order of from about 0.001 inches to about 0.002 inches, and comprise porous ePTFE, having a pore size within the range of from about 10 microns to about 100 microns.
- the composite stack is heated to a temperature of from about 200° F to about 300° F, for about 1 minute to about 5 minutes under pressure to provide a finished composite membrane assembly with embedded leafs 50, as illustrated schematically in Figure 16.
- the final composite membrane has a thickness within the range of from about 0.001 inches to about 0.010 inches, and, preferably, is about 0.002 to about 0.003 inches in thickness.
- the thicknesses and process parameters of the foregoing may be varied considerably, depending upon the materials of the bonding layer 254, first membrane 250, and second membrane 252.
- the resulting finished composite membrane film 52 has a plurality of "unbonded" windows or areas 256 suitable for cellular attachment and/or ingrowth.
- the attachment areas 256 are bounded by leafs 50, and the cross-hatch or other wall pattern formed by the bonding layer 254.
- a regular window 256 pattern is produced in the bonding layer 254.
- a composite membrane film 52 when used in the stent embodiment illustrated in Figures 12-13, provides a barrier and prevents emboli from being shed from the stented region, when the self expanded segment 2 apposes ostial O and aortic Ao regions of a vessel.
- the invention can be applied to any site of branching of an artery, vein, bronchus, duct, ureter, urethra, and other lumen including but not limited to the junction of the common, internal, and external carotid arteries, the junction of the main, left anterior descending, and circumflex coronary arteries, the junction of the left main or right coronary artery with the aorta, the junction of the aorta with the subclavian artery, and the junction of the aorta with the carotid artery.
Abstract
A renal stent includes a balloon expandable segment intended for deployment in the renal vessel and a self expanding segment intended for deployment in the aortic segment. One or both of the balloon expandable and self expanding segments can be deployed in the ostial region of the renal vessel, typically the renal artery. The balloon expandable segment provides superior radial strength for maintaining dilated diameter of the renal vessel. The self expanding segment expands to conform to the flared ostial and aortic regions of the vessel. The self expanding segment can be balloon dilated to enhance conformance of the self expanding stented segment to the ostial and aortic regions.
Description
STENT AND STENT DELIVERY SYSTEM FOR OSTIAL LOCATIONS IN A CONDUIT
FIELD OF THE INVENTION [01] The present invention relates to luminal implants, and, more particularly, to stents for use in treating vascular disease.
BACKGROUND OF THE INVENTION
[02] Stents are widely used for supporting a lumen structure in a patient's body. For example, a stent may be used to maintain patency of a coronary artery, other blood vessel or other body lumen such as the ureter, urethra, bronchus, esophagus, or other passage. A stent is typically a metal, tubular structure, although polymer stents are known. Stents can be permanent enduring implants, or can be bioabsorbable at least in part. Bioabsorbable stents can be polymeric, bio- polymeric, ceramic, bio-ceramic, or metallic, and may elute over time substances such as drugs.
[03] In certain stent designs, the stent is an open-celled tube that is expanded by an inflatable balloon at the deployment site. Another type of stent is of a "self-expanding" type. A self-expanding stent does not use a balloon or other source of force to move from a collapsed state to an expanded state. A self- expanding stent is passed through the body lumen in a collapsed state. At the point of an obstruction, or other deployment site in the body lumen, the stent is expanded to its expanded diameter for its intended purpose. An example of a self-expanding stent is a coil structure that is secured to a stent delivery device under tension in a collapsed state. At the deployment site, the coil is released so that the coil can expand to its enlarged diameter. Coil stents can be manufactured using a variety of methods, such as winding of wire, ribbon, or sheet on a mandrel or by laser cutting from a tube, followed by the appropriate heat treatments. Another type of self expanding stent is an open-celled tube made from a self-expanding material, for example, the Protege GPS stent from ev3, Inc. of Plymouth, MN. Open cell tube stents are commonly made by laser cutting of tubes, or cutting patterns into sheets followed by or preceded by welding the sheet into a tube shape, and other methods.
[04] The shape, length and other characteristics of a stent are typically chosen based on the location in which the stent will be deployed. However, selected segments of the human vasculature present specific challenges due to their shape and configuration. One such situation involves the ostium of short renal arteries within the human body.
[05] Conventional stents are generally designed for segments of long cylindrical vessels. When such stents are deployed at the ostium of short renal arteries, in an attempt to prevent further progression of arteriosclerosis disease from aorta into renals, they may extend into the aorta and disrupt the normally laminar blood flow. This result further compounds an existing need to minimize disruption of the flow pattern at the ostium. In addition, stents are hard to position on a consistent basis at the precise ostial location desired, and placement of renal stents can release arteriosclerotic debris from the treatment area. Such debris will flow distally into the kidney and embolize, causing impaired renal function. [06] Accordingly, it is desirable to flare the end of a stent to minimize disruption to flow pattern at ostium and to simplify re-access in the future. However, existing stents are hard to flare with existing expansion means. Stents suitable for expansion of renal arteries must have high radial strength when expanded to resist vessel forces tending to radially collapse the stent. This need for high stent strength makes suitable stents difficult to flare. A stent configuration designed to address these concerns is disclosed in commonly assigned United States Patent Application Serial No. 10/816, 784, filed April 2, 2004, by Paul J. Thompson and Roy K. Greenberg, US Publication Number US 2004/0254627 A1. However, the stent, when flared, has a lower percentage of coverage of vessel wall at flared regions than is desirable. It is known that stent struts, when expanded into contact with the vessel wall, should cover a certain percentage of the internal vessel wall area in order to prevent prolapse of tissue through the open spaces between stent struts.
[07] Accordingly, a need exists for a stent that can be placed at the renal ostium which is both strong and provides a high percentage of vessel wall coverage. [08] Further need exists for a stent that will minimize disruption of the flow pattern at the ostium and which will lower the risk of embolization during deployment.
SUMMARY OF THE INVENTION
[09] According to one aspect of the present invention, a renal stent comprises a balloon expandable segment which is deployed in the renal vessel and a self expanding segment which is deployed in the aortic segment. Either or both of the balloon expandable and self expanding segments can be deployed in the ostial region of the renal vessel, typically the renal artery. The balloon expandable segment provides superior radial strength for maintaining dilated diameter of the renal vessel. The self expanding segment expands to conform to the flared ostial and aortic regions of the vessel. The self expanding segment can be balloon dilated to enhance conformance of the self expanding stented segment to the ostial and aortic regions.
[10] According to one aspect of the present invention, a stent for insertion into a body lumen comprises a first tubular, self-expanding section; a second tubular, balloon-expandable section; and a mechanism for limiting axial movement of the first and second tubular sections relative to each other.
[11] According to a second aspect of the present invention, a stent for insertion into a body lumen comprises a tube formed of a uniform material having i) a first section to which a first process is applied, and ii) a second section to which a second process is applied; and wherein the expansion characteristics of the first and second sections within the body lumen are different.
[12] According to a third aspect of the present invention, a stent for insertion into a body lumen comprising a plurality of sections, each section defining a plurality of cells, each cell atleast partially defined by a plurality of struts, selected of the struts in each section connecting to struts of an adjacent stent section, wherein the number of connecting struts between adjacent segments increases proximally.
[13] According to a fourth aspect of the present invention, system for delivering a medical device within a body lumen comprises: a tubular catheter having proximal and distal ends and comprising an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising i) a first tubular, balloon- expandable section; and ii) a second tubular, self-expanding section; and wherein the first section of the medical device is disposed intermediate the first balloon and
the outer shaft member, and wherein the second section of the medical device is disposed intermediate the second balloon and outer shaft member.
[14] According to a fifth aspect of the present invention, a method for placement of a medical device within a body lumen comprises: disposing a delivery system within the body lumen, the delivery system comprising: a tubular catheter having an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising: i) a first balloon-expandable section disposed intermediate the first balloon and the outer shaft member, and a second self-expanding section disposed intermediate the second balloon and outer shaft member. The method further comprises withdrawing the outer shaft member proximally to expose the first balloon- expandable section of the medical device to the body lumen; inflating the first balloon to expand the first section of the medical device against the body lumen; withdrawing the outer shaft member proximally to expose the second self-expanding section of the medical device to the body lumen; and inflating the second balloon to expand the second section of the medical device at least partially against the body lumen.
BRIEF DESCRIPTION OF THE DRAWINGS [15] The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying drawings in which:
[16] Figures 1 -4 illustrate conceptually a partial cross-sectional diagram of a stent and a plan view of a stent delivery system in accordance with the present invention;
[17] Figure 5 illustrates conceptually an alternate embodiment of the delivery system of Figures 1-4;
[18] Figure 6 illustrates conceptually a cross-sectional diagram of another embodiment of a stent in accordance with the present invention; [19] Figure 7 illustrates conceptually a plan view of an alternative embodiment of a stent in accordance with the present invention;
[20] Figure 8 is a schematic diagram of a stent in accordance with the present invention;
[21] Figure 9 illustrates conceptually a plan view of an alternate embodiment of a stent in accordance with the present invention; [22] Figure 10 illustrates conceptually the profile of a flared stent in accordance with the present invention;
[23] Figures 11 and 11A are schematic diagrams of an alternate embodiment of a stent in accordance with the present invention;
[24] Figures 12 and 13 illustrate conceptually a plan view of another embodiment of a stent in accordance with the present invention;
[25] Figures 14 is a schematic diagrams of a film material used in the stent embodiment of Figure 17;
[26] Figures 15 and 16 illustrate conceptually exploded and compressed cross-sectional diagram, respectively, of a film suitable for use with the stent embodiment of Figure 17; and
[27] Figure 17 illustrates conceptually a plan view of another embodiment of a stent in accordance with the present invention.
DETAILED DESCRIPTION [28] Figure 1 illustrates a stent 15 in accordance with the present invention.
Stent 15 comprises a balloon expandable stent segment 12 and a self expanding stent segment 13. Balloon expandable stent segment 12 may comprise stainless steel alloys, cobalt chrome alloys, titanium, tantalum, platinum, gold, or other materials or their alloys as are known in the art. The self expanding stent segment 13 may be comprise high elastic limit materials such as Elgiloy, cobalt chrome alloys, or other materials as are known in the art. The self expanding stent may comprise so-called shape-memory metals such as nitinol. Shape-memory metal stents can self-expand when thermo mechanically processed to exhibit superelastic material properties. Such shape-memory stents can also self-expand through use of a pre- programmed shape memory effect. Stents processed to exhibit a shape memory effect experience a phase change at the elevated temperature of the human body.
The phase change results in expansion of the stent from a collapsed state to an enlarged state
[29] Figures 1 — 4 show delivery of the inventive stent 15 to a treatment site. In use, the renal stent 15 is delivered to the treatment site, typically a renal artery, on a catheter 18 with both an outer sheath 11 coaxially retractable from inner balloons 10, 16, as illustrated in figure 1. The outer sheath 11 constrains at least the self expandable segment 13 of the stent 15. Distal balloon 10 is used to expand the balloon expandable segment 12 of the stent 15. Optional proximal balloon 16 may be used to dilate the self expanding segment 13 of stent 15. At the treatment site, distal balloon 10 is inflated to expand the balloon expandable segment 12 and dilate the artery RA, thereby fixing the stent at the treatment site, as illustrated in Figure 2. Outer sheath 11 is then withdrawn, preferably before deflation of distal balloon 10, and self expanding segment 13 diametrically enlarges and conforms to the typically flared ostial O and/or aortic Ao regions near the vessel, as illustrated in Figure 3. Optionally, the flared portion of the stent 15, that is the portion of the stent 15 opposite the ostial O and aortic Ao regions, can be further dilated with proximal balloon 16. Inflated distal balloon 10 helps to axially anchor catheter 18 in vessel RA so that proximal balloon 16 can deliver force to self expandable stent segment 13 and thereby enhance stent segment 13 apposition to ostial and aortic regions of the vessel. Balloons 10 and 16 are then deflated. Optionally the outer sheath 11 is advanced relative to balloons 10 and 16 to cover the balloons in whole or in part, and the stent delivery catheter 18 is withdrawn from the treatment site, as illustrated in Figure 4. It is not necessary to position balloon expandable stent segment 12 in the vessel RA with precision because subsequent expansion of the self expanding stent segment 13 will assure continuous coverage of the vessel wall in regions RA1 O, and Ao. Stenting of the vessel RA, ostium O, and aorta Ao is accomplished by delivery of one stent to the region thereby reducing the amount of debris generated during stenting as compared to procedures involving delivery of multiple devices.
[30] Fig. 5 shows an alternate embodiment of a delivery system 18' shown in Figures 1-4. In most respects the delivery system shown in Fig. 5 is used in a manner similar to that described above in conjunction with Figs. 1 - 4. In this embodiment, balloon 17 provides the function of both balloons 10 and 16 of delivery
system 18'. With sheath 11 covering self expanding stent segment 13 and balloon portion 17b, balloon portion 17a is used to dilate balloon expandable stent segment 12. Subsequently, balloon 17 is deflated to a pressure low enough to proximally withdraw sheath 11 until it no longer covers self expanding stent segment 13 and balloon portion 17b. Next, balloon 17 is inflated, causing balloon portion 17a to anchor catheter 18 in the vessel and causing balloon portion 17b to further dilate self expanding stent portion 13. In this embodiment, balloon 17 may be constructed from appropriate materials so as to have differing compliance characteristics between sections 17a and 17b at the same inflation pressure, or , balloon 17 may be formed to assume a profile similar to that illustrated in Figure 5.
[31] Fig. 6 illustrates another embodiment of the inventive stent 15 in which the stent segments are at least partially coextensive. In an illustrative embodiment, the balloon expandable segment 1 disposed within the self expanding segment 2, as shown. Alternatively, the balloon expandable segment 1 can be arranged outside of the self expanding segment 2 (not shown). The balloon expandable and self expandable segments may be attached to each other so as to limit axial motion of one segment relative to the other. The stent segments can be attached to one another using means 3 known in the art, including, but not limited to, mechanical interlock, welding, adhesive bonding, over molding, sintering, diffusion bonding, cladding, explosive bonding, ultrasonic welding. If more than one attachment site is required, stent segments 1 and 2 may have matched axial shortening or lengthening during expansion to prevent detachment of attachment sites of means 3. Alternatively, stent segments 1 and 2 can have mis-matched axial shortening or lengthening during expansion provided the attachment sites of means 3 are designed to accommodate such mis-match without becoming detached.
[32] Fig. 7 illustrates another alternative embodiment of the inventive stent 15. In this embodiment, stent 15 comprises a balloon expandable segment 1 and a self expanding segment 2. The balloon expandable segment 1 is attached to the self expanding segment 2 at attachment region 20. The balloon and self expandable stent segments may be attached to each other so as to limit axial motion of one segment relative to the other. The stent segments can be attached to one another using means known in the art, including, but not limited to, mechanical interlock,
welding, adhesive bonding, over molding, sintering, diffusion bonding, cladding, explosive bonding, ultrasonic welding. For example, a stent segment 1 comprising a titanium alloy can be welded to a stent segment 2 comprising Nitinol. Figure 8 illustrates an example of implementation of the stent of figure 7. In figure 8, stent 15 comprises laser cut tubular stent segments 1 and 2 welded at attachment points 5 in attachment region 20. In figure 8, the longitudinal axis of stent 15 is indicated in the figure by dashed line "X."
[33] Figure 9 illustrates another alternative embodiment of a stent 15 having a singular piece of material to which different processes have been applied. As shown, stent 15 comprises stent segments 1 and 2 having different overall processing histories. For example, a body temperature superelastic nitinol stent may be heated in the region of stent segment 1 to raise the transition temperature in segment 1 to above body temperature, resulting in a balloon expandable stent segment 1 and a self expanding stent segment 2. Similarly an Elgiloy or cobalt- chrome alloy stent, initially heavily work hardened and self expanding, may be preferentially annealed to render a portion of the stent balloon expandable.
[34] Fig. 10 illustrates a side cut-away profile of another alternative embodiment of a stent 15 having cell designs with the same number of struts along its length. For example, in non-flared region 41 having stent diameter D, the stent struts have approximately 14 - 18% metal coverage area. In flared region 42 having stent diameter 2D, the stent struts have approximately 7 - 9% metal coverage area. In flared region 43 having stent diameter 4D1 the stent struts have approximately 3.5 — 4.5% metal coverage area. It is known that stents having metal coverage area less than approximately 14 — 18% do not perform well due to tissue prolapse through the cells of the stent into the stented lumen, and due to potential extrusion of atheromatous material through the stent metal coverage area into the stented vessel lumen. To avoid sub-par stent performance in the stented and flared region, it is desirable to increase the metal coverage area to the approximately 15 - 18% range. One way to do this is by increasing the number of stent struts in region of the stent that will be flared as compared to the number of struts in the region of the stent that will not be flared.
[35] Figures 11 and 11A illustrate a stent embodiment for increasing the percent metal coverage area in the flared region of the deployed stent. In figure 11 the number of struts progressively increases in regions 41 , 42, and 43 respectively. In figure 11 the compressed stent diameter is held constant while the compressed strut spacing varies in segments 41 , 42, and 43. Attachment points between regions in this embodiment may comprise a laser cut tube segment, as illustrated in detail in Figure 11 A, with the number of connecting struts increasing between adjacent segments as the density of the cell/strut configuration increases between adjacent segments. In one embodiment, segment 41 comprises 6 struts, segment 42 comprises 12 struts, and segment 43 comprises 24 struts. It is recognized that any number of struts and segments may be used to produce an overall stented region metal coverage area of a target value appropriate to the anatomy. For arteries the illustrative target metal coverage area is thought to be approximately 15 — 18%.
[36] Another embodiment of stent 15 is illustrated in Figs. 12 and 13. Stent 15 comprises balloon expandable segment 1 and self expanding segment 2. Balloon expandable segment 1 may have the construction and function similar any of the embodiments described herein. Self expandable segment 2 comprises leafs 50 and film 52. Leafs 50 comprise materials such as those described above for self expanding stent segment 2. Leafs 50 are attached to balloon expandable stent segment 1 using techniques similar to those described above regarding the embodiment of Fig. 7.
[37] Film 52 is attached to leafs 50 by bonding. Film 52 may comprise any of a variety of membranous materials including those which facilitate cellular ingrowth, such as ePTFE. The suitability of alternate materials for film 52 can be determined through routine experimentation. The film 52 may be provided on one or both radially facing sides of the leafs 50. In one embodiment, the film 52 comprises two layers, with one layer on each side of leafs 50. The two layers may be bonded to each other around the leafs using any of a variety of techniques, for example by heat bonding, with or without an intermediate bonding layer such as polyethylene or FEP, adhesives, sutures, or other techniques which will be apparent to those of recently skill in the arts in view of the disclosure herein. The film 52 preferably has a
thickness of no more than about 0.006" and a pore size within the range of from approximately 5μm to approximately 60μm.
[38] Film 52 in one embodiment preferably is securely attached to leafs 50 and retains a sufficient porosity to facilitate cellular ingrowth and/or attachment. One method of manufacturing a suitable composite membrane film 52 is illustrated in Figures 14-17. As illustrated schematically in Figure 14, a bonding layer 254 preferably comprises a mesh or other porous structure having an open surface area within the range of from about 10% to about 90%. In one embodiment, the open surface area of the mesh is within the range of from about 30% to about 60%. The opening or pore size of the bonding layer 254 may be within the range of from about 0.005 inches to about 0.050 inches, and, in one embodiment, is about 0.020 inches. The thickness of the bonding layer 254 can be varied widely, and is generally within the range of from about 0.0005 inches to about 0.005 inches. In a illustrative embodiment, the bonding layer 254 has a thickness of about 0.001 to about 0.002 inches. One suitable polyethylene bonding mesh is commercially available from Smith & Nephew Inc., Memphis, Tennessee under the code SN9.
[39] Figure 15 is an exploded view illustrating the relationship between first membrane 250, second membrane 252, bonding layer 254 and leafs 50. Bonding layer 254 is disposed adjacent one or both sides of leafs 50. The bonding layer 254 and leafs 50 are then positioned in-between a first membrane 250 and a second membrane 252 to provide a composite membrane stack. The first membrane 250 and second membrane 252 may comprise any of a variety of materials and thicknesses, depending upon the desired functional result. Generally, the membrane has a thickness within the range of from about 0.0005 inches to about 0.010 inches. In one embodiment, the membranes 250 and 252 each have a thickness on the order of from about 0.001 inches to about 0.002 inches, and comprise porous ePTFE, having a pore size within the range of from about 10 microns to about 100 microns.
[40] The composite stack is heated to a temperature of from about 200° F to about 300° F, for about 1 minute to about 5 minutes under pressure to provide a finished composite membrane assembly with embedded leafs 50, as illustrated schematically in Figure 16. The final composite membrane has a thickness within
the range of from about 0.001 inches to about 0.010 inches, and, preferably, is about 0.002 to about 0.003 inches in thickness. However, the thicknesses and process parameters of the foregoing may be varied considerably, depending upon the materials of the bonding layer 254, first membrane 250, and second membrane 252. [41] As illustrated in top plan view in Figure 17, the resulting finished composite membrane film 52 has a plurality of "unbonded" windows or areas 256 suitable for cellular attachment and/or ingrowth. The attachment areas 256 are bounded by leafs 50, and the cross-hatch or other wall pattern formed by the bonding layer 254. Preferably, a regular window 256 pattern is produced in the bonding layer 254.
[42] The foregoing procedure allows the bonding mesh to flow into the first and second membranes 250 and 252 and gives the composite membrane film 52 greater strength (both tensile and tear strength) than the components without the bonding mesh. The composite membrane allows uniform bonding while maintaining porosity of the membrane film 52, to facilitate tissue attachment. By flowing the thermoplastic bonding layer into the pores of the outer mesh layers 250 and 252, the composite flexibility is preserved and the overall composite layer thickness can be minimized. In another embodiment film 52 may be non-porous and comprise a polymer such as polyurethane or silicone. [43] A composite membrane film 52, when used in the stent embodiment illustrated in Figures 12-13, provides a barrier and prevents emboli from being shed from the stented region, when the self expanded segment 2 apposes ostial O and aortic Ao regions of a vessel.
[44] While this document has described an invention mainly in relation to renal artery stenting, it is envisioned that the invention can be applied to other conduits in the body as well including arteries, veins, bronchi, ducts, ureters, urethra, and other lumens intended for the passage of air, fluids, or solids. The invention can be applied to any site of branching of an artery, vein, bronchus, duct, ureter, urethra, and other lumen including but not limited to the junction of the common, internal, and external carotid arteries, the junction of the main, left anterior descending, and circumflex coronary arteries, the junction of the left main or right coronary artery with
the aorta, the junction of the aorta with the subclavian artery, and the junction of the aorta with the carotid artery.
[45] While the various embodiments of the present invention have related to stents and stent delivery systems, the scope of the present invention is not so limited. Further, while choices for materials and configurations may have been described above with respect to certain embodiments, one of ordinary skill in the art will understand that the materials described and configurations are applicable across the embodiments.
[46] What is claimed is:
Claims
1. A stent for insertion into a body lumen comprising: a first tubular, self-expanding section; a second tubular, balloon-expandable section; and a mechanism for limiting axial movement of the first and second tubular sections relative to each other.
2. The stent of claim 1 wherein the mechanism for limiting axial movement comprises: an attachment device mechanically coupling the first and second tubular sections relative to each other.
3. The stent of claim 2 wherein the attachment device mechanically couples an end of the first tubular section to an end of the second tubular section.
4. The stent of claim 2 wherein a portion of the first tubular section is coextensive with a portion of the second tubular section.
5. The stent of claim 4 wherein each of the first and second tubular sections comprise a plurality of struts and the an attachment device comprises at least one bond formed between a strut of the first tubular sections and a strut of the second tubular sections by a process selected from the group consisting of mechanical interlock, welding, adhesive bonding, over molding, sintering, diffusion bonding, cladding, explosive bonding, and ultrasonic welding.
6. The stent of claim 1 wherein each of the first and second tubular sections comprise a plurality of struts within a unit of length and wherein the number of struts within the unit of length in the first section is different from the number of struts within the unit of length in the second section.
7. The stent of claim 6 wherein the wherein the number of struts within the unit of length in the second section is greater than the number of struts within the unit of length in the first section.
8. The stent of claim 7 wherein the unit of length is measured axially from a first end of the stent to a second end of the stent.
9. The stent of claim 7 wherein the unit of length is measured circumferentially around a diameter of the stent in an unexpanded state.
10. The stent of claim 7 wherein the stent further comprises: a third tubular, balloon-expandable section having a number of struts within the unit of length that is greater than the number of struts within the unit of length in the second section.
11. The stent of claim 1 wherein the second section comprises: a plurality leafs attached to the first section; and a film attached to the plurality leafs and extending therebetween.
12. The stent of claim 11 wherein the film comprises first and second layers of material disposed on opposite sides of said leafs and bonded together.
13. The stent of claim 9 wherein the first and second layers of material are bonded together by a process selected from the group consisting of heat bonding, adhesive bonding or suturing.
14. The stent of claim 1 in combination with a delivery system comprising: a catheter having a balloon carried at a distal end thereof; a proximal portion of the balloon having an expanded diameter greater than an expanded diameter of a more distal portion of the balloon.
15. The stent of claim 1 in combination with a delivery system comprising: a catheter having first and second balloons carried at a distal end thereof; a proximal of the balloons having an expanded diameter greater than an expanded diameter of a more distal of the balloons.
16. A stent for insertion into a body lumen comprising: a tube formed of a uniform material and comprising: i) a first section to which a first process is applied, and ii) a second section to which a second process is applied; wherein the expansion characteristics of the first and second sections within the body lumen are different.
17. A stent for insertion into a body lumen comprising a plurality of sections, each section defining a plurality of cells, each cell atleast partially defined by a plurality of struts, selected of the struts in each section connecting to struts of an adjacent stent section, wherein the number of connecting struts between adjacent segments increases proximally.
18. A system for delivering a medical device within a body lumen comprising: a tubular catheter having proximal and distal ends and comprising an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising: a first tubular, balloon-expandable section; and a second tubular, self-expanding section; wherein the first section of the medical device is disposed intermediate the first balloon and the outer shaft member, and wherein the second section of the medical device is disposed intermediate the second balloon and outer shaft member.
19. The system of claim 18 wherein the second balloons has an expanded diameter greater than an expanded diameter of the first balloons.
20. A method for placement of a medical device within a body lumen comprising: disposing a delivery system within the body lumen, the delivery system comprising: a tubular catheter having an outer shaft member slidably disposed about an inner shaft member; first and second balloons carried at a distal end of inner shaft member; a medical device comprising: a first balloon-expandable section disposed intermediate the first balloon and the outer shaft member, and a second self-expanding section disposed intermediate the second balloon and outer shaft member; withdrawing the outer shaft member proximally to expose the first balloon- expandable section of the medical device to the body lumen; inflating the first balloon to expand the first section of the medical device against the body lumen; withdrawing the outer shaft member proximally to expose the second self- expanding section of the medical device to the body lumen; and inflating the second balloon to expand the second section of the medical device at least partially against the body lumen.
21. The method of claim 20 wherein the body lumen is selected from the group consisting of coronary artery, ureter, urethra, bronchus, and esophagus.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES06846296T ES2425948T3 (en) | 2005-11-14 | 2006-11-14 | Cannula delivery system for ostial sites within a duct |
EP06846296.9A EP1954224B1 (en) | 2005-11-14 | 2006-11-14 | Stent delivery system for ostial locations in a conduit |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73658505P | 2005-11-14 | 2005-11-14 | |
US60/736,585 | 2005-11-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007059483A2 true WO2007059483A2 (en) | 2007-05-24 |
WO2007059483A3 WO2007059483A3 (en) | 2007-07-26 |
Family
ID=37806238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060865 WO2007059483A2 (en) | 2005-11-14 | 2006-11-14 | Stent and stent delivery system for ostial locations in a conduit |
Country Status (4)
Country | Link |
---|---|
US (1) | US7632302B2 (en) |
EP (1) | EP1954224B1 (en) |
ES (1) | ES2425948T3 (en) |
WO (1) | WO2007059483A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009144463A1 (en) * | 2008-05-31 | 2009-12-03 | Shane Gieowarsingh | Stent |
WO2010148524A1 (en) * | 2009-06-22 | 2010-12-29 | Otto Hess | Stent and cardiac catheter for replacing a heart valve |
WO2014176364A1 (en) | 2013-04-23 | 2014-10-30 | Medical Ingenuities, LLC | Interconnection between selectively-expandable and self-expandable sections of an ostial stent |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
US9066825B2 (en) | 2012-05-14 | 2015-06-30 | C.R. Bard, Inc. | Uniformly expandable stent |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2012076060A2 (en) | 2010-12-09 | 2012-06-14 | Advanced Bionics Ag | Implantable actuator of a hearing aid |
AU2012225575B9 (en) | 2011-03-08 | 2015-08-20 | W. L. Gore & Associates, Inc. | Medical device for use with a stoma |
WO2012149167A2 (en) | 2011-04-26 | 2012-11-01 | Christopher Gerard Kunis | Method and device for treatment of hypertension and other maladies |
US20130030513A1 (en) * | 2011-07-25 | 2013-01-31 | Corrigan Jr Richard F | Ostial stent |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021375A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Percutaneous mitral valve replacement and sealing |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) * | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
DE102012220129B4 (en) * | 2012-11-05 | 2022-12-15 | Optimed Medizinische Lnstrumente Gmbh | stent |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
US9839543B2 (en) | 2013-03-14 | 2017-12-12 | Cook Medical Technologies Llc | Multi-stage balloon catheter |
DE202014100863U1 (en) * | 2014-02-26 | 2014-03-14 | Cormedics Medizintechnik GmbH | Guidewire for medical devices |
US11712230B2 (en) | 2014-05-02 | 2023-08-01 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US11439396B2 (en) | 2014-05-02 | 2022-09-13 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US10363040B2 (en) | 2014-05-02 | 2019-07-30 | W. L. Gore & Associates, Inc. | Anastomosis devices |
CA2947896A1 (en) | 2014-05-23 | 2015-11-26 | Boston Scientific Scimed, Inc. | Deployment system incorporating application of adhesive |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
US10076428B2 (en) | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
US11724075B2 (en) | 2017-04-18 | 2023-08-15 | W. L. Gore & Associates, Inc. | Deployment constraining sheath that enables staged deployment by device section |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
US11291570B2 (en) | 2018-04-27 | 2022-04-05 | Cook Medical Technologies Llc | Hybrid stent and delivery system |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1A (en) | 1836-07-13 | John Ruggles | Locomotive steam-engine for rail and other roads | |
US5607444A (en) | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US20040254627A1 (en) | 2003-04-04 | 2004-12-16 | Thompson Paul J. | Stent with end adapted for flaring |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0257091B1 (en) | 1986-02-24 | 1993-07-28 | Robert E. Fischell | An intravascular stent and percutaneous insertion system |
IL94138A (en) | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
US5372600A (en) | 1991-10-31 | 1994-12-13 | Instent Inc. | Stent delivery systems |
US5527338A (en) | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
WO1996013228A1 (en) | 1994-10-27 | 1996-05-09 | Schneider (Usa) Inc. | Stent delivery device |
US5749851A (en) * | 1995-03-02 | 1998-05-12 | Scimed Life Systems, Inc. | Stent installation method using balloon catheter having stepped compliance curve |
US5632762A (en) | 1995-11-09 | 1997-05-27 | Hemodynamics, Inc. | Ostial stent balloon |
US6203569B1 (en) | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
US6096071A (en) | 1998-03-26 | 2000-08-01 | Yadav; Jay S. | Ostial stent |
AU2225999A (en) | 1998-01-16 | 1999-08-02 | Emory University | Catheter and method of ostial stent placement |
US6132461A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6132460A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6290728B1 (en) | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
US7231327B1 (en) | 1999-12-03 | 2007-06-12 | Digital Sandbox | Method and apparatus for risk management |
US6315708B1 (en) * | 2000-03-31 | 2001-11-13 | Cordis Corporation | Stent with self-expanding end sections |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US6945994B2 (en) * | 2001-12-05 | 2005-09-20 | Boston Scientific Scimed, Inc. | Combined balloon-expanding and self-expanding stent |
US6752826B2 (en) * | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
EP1469794B1 (en) * | 2002-01-28 | 2009-03-18 | OrbusNeich Medical, Inc. | Flared ostial endoprosthesis and delivery system |
US7288111B1 (en) * | 2002-03-26 | 2007-10-30 | Thoratec Corporation | Flexible stent and method of making the same |
US6969402B2 (en) | 2002-07-26 | 2005-11-29 | Syntheon, Llc | Helical stent having flexible transition zone |
US7214240B2 (en) | 2003-03-20 | 2007-05-08 | Cordis Corporation | Split-bridge stent design |
US8109987B2 (en) * | 2003-04-14 | 2012-02-07 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US8083791B2 (en) * | 2003-04-14 | 2011-12-27 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US7105015B2 (en) * | 2003-06-17 | 2006-09-12 | Medtronic Vascular, Inc. | Method and system for treating an ostium of a side-branch vessel |
CA2532028A1 (en) | 2003-09-03 | 2005-04-14 | Boston Scientific Limited | Stent with overlapped point markers |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
WO2005077433A1 (en) * | 2004-02-09 | 2005-08-25 | Cook Biotech Incorporated | Stent graft devices having collagen coating |
-
2006
- 2006-11-14 ES ES06846296T patent/ES2425948T3/en active Active
- 2006-11-14 US US11/559,455 patent/US7632302B2/en active Active
- 2006-11-14 EP EP06846296.9A patent/EP1954224B1/en not_active Not-in-force
- 2006-11-14 WO PCT/US2006/060865 patent/WO2007059483A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1A (en) | 1836-07-13 | John Ruggles | Locomotive steam-engine for rail and other roads | |
US5607444A (en) | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US20040254627A1 (en) | 2003-04-04 | 2004-12-16 | Thompson Paul J. | Stent with end adapted for flaring |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009144463A1 (en) * | 2008-05-31 | 2009-12-03 | Shane Gieowarsingh | Stent |
WO2010148524A1 (en) * | 2009-06-22 | 2010-12-29 | Otto Hess | Stent and cardiac catheter for replacing a heart valve |
US9066825B2 (en) | 2012-05-14 | 2015-06-30 | C.R. Bard, Inc. | Uniformly expandable stent |
US10588765B2 (en) | 2012-05-14 | 2020-03-17 | C. R. Bard, Inc. | Uniformly expandable stent |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
WO2014176364A1 (en) | 2013-04-23 | 2014-10-30 | Medical Ingenuities, LLC | Interconnection between selectively-expandable and self-expandable sections of an ostial stent |
EP2988705A4 (en) * | 2013-04-23 | 2016-11-02 | Medical Ingenuities Llc | Interconnection between selectively-expandable and self-expandable sections of an ostial stent |
US10456278B2 (en) | 2013-04-23 | 2019-10-29 | Medical Ingenuities, LLC | Interconnection between selectively-expandable and self-expandable sections of an ostial stent |
Also Published As
Publication number | Publication date |
---|---|
ES2425948T3 (en) | 2013-10-18 |
WO2007059483A3 (en) | 2007-07-26 |
US7632302B2 (en) | 2009-12-15 |
US20070129785A1 (en) | 2007-06-07 |
EP1954224A2 (en) | 2008-08-13 |
EP1954224B1 (en) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1954224B1 (en) | Stent delivery system for ostial locations in a conduit | |
US10687967B2 (en) | Stretchable stent and delivery system | |
US10188534B2 (en) | Stent having reduced passage of emboli and stent delivery system | |
US7238197B2 (en) | Endoprosthesis deployment system for treating vascular bifurcations | |
US6491719B1 (en) | Tubular endoluminar prosthesis having oblique ends | |
JP2020114545A (en) | Medical device | |
AU2005289393B2 (en) | Thin film medical device and delivery system | |
US7226475B2 (en) | Stent with variable properties | |
US6565600B2 (en) | Articulated expandable intraluminal stent | |
US8728143B2 (en) | Endoprosthesis deployment system for treating vascular bifurcations | |
US20030139803A1 (en) | Method of stenting a vessel with stent lumenal diameter increasing distally | |
US20130197624A1 (en) | Stent | |
US20050154447A1 (en) | Ostium stent system | |
JP2010532683A (en) | Stent with bioabsorbable membrane | |
JP2004531347A (en) | Highly flexible and flexible stent | |
JP2009505775A (en) | Stent with expanding side branch configuration | |
MX2007003191A (en) | Thin film medical device and delivery system. | |
US8814929B2 (en) | Stent and stent delivery system for side-branch locations in a conduit | |
JP2009509629A (en) | Hybrid branch stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006846296 Country of ref document: EP |